Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2026-01-06 @ 12:11 AM
Study NCT ID:
NCT03333057
Status:
COMPLETED
Last Update Posted:
2022-01-04
First Post:
2017-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
Sponsor:
Novaliq GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NVU-002 (SEECASE)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None